Boston Medical Group vs Emerge Weight Loss
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Boston Medical Group
Best for budget-conscious shoppersStarting at $66/mo
Emerge Weight Loss
Best for patients committed to tirzepatide as their drug of choiceStarting at $299/mo
Side-by-Side Comparison
| Feature | Boston Medical Group | Emerge Weight Loss |
|---|---|---|
| Overall Score | ✓7.7/10 | 7.6/10 |
| Starting Price | ✓$66/mo | $299/mo |
| Customer Rating | — | — |
| Features | 3 features | ✓4 features |
| States Available | 50 | 50 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Boston Medical Group
Pros
- ✓Aggressively low monthly pricing
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
Cons
- ✗Limited public information on program details
Emerge Weight Loss
Pros
- ✓Tirzepatide-focused (largest effect-size compounded GLP-1)
- ✓Wide dose range available
- ✓Physician-supervised telemedicine model
Cons
- ✗No semaglutide option — limits flexibility if tirzepatide tolerability is poor
- ✗Less brand recognition than Henry Meds, Mochi, or SkinnyRx
Our Verdict
Boston Medical Group edges out Emerge Weight Loss with a higher overall score of 7.7/10 and is particularly strong for budget-conscious shoppers. Emerge Weight Loss remains a solid alternative, especially if you're looking for patients committed to tirzepatide as their drug of choice.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.